⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAGX News
Jaguar Health, Inc.
Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Presenting on Emerging Growth Conference 93 Day 2 on June 11; Register to live stream
globenewswire.com
CIA
ZENA
JAGX
USAU
JUNS
VGZ
VWAV
EEIQ
SBC
NWTG
NVA
UMAC
MTVA
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
globenewswire.com
CIA
ZENA
JAGX
USAU
JUNS
VGZ
VWAV
EEIQ
SBC
NWTG
NVA
UMAC
MTVA
Form 8-K
sec.gov
JAGX
Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Jaguar Health Compliant with Nasdaq Bid Price Rule
accessnewswire.com
JAGX